Literature DB >> 17574010

The MCT8 thyroid hormone transporter and Allan-Herndon-Dudley syndrome.

Charles E Schwartz1, Roger E Stevenson.   

Abstract

Thyroid hormone is essential for the proper development and function of the brain. The active form of thyroid hormone is T(3), which binds to nuclear receptors. Recently, a transporter specific for T(3), MCT8 (monocarboxylate transporter 8) was identified. MCT8 is highly expressed in liver and brain. The gene is located in Xq13 and mutations in MCT8 are responsible for an X-linked condition, Allan-Herndon-Dudley syndrome (AHDS). This syndrome is characterized by congenital hypotonia that progresses to spasticity with severe psychomotor delays. Affected males also present with muscle hypoplasia, generalized muscle weakness, and limited speech. Importantly, these patients have elevated serum levels of free T(3), low to below normal serum levels of free T(4), and levels of thyroid stimulating hormone that are within the normal range. This constellation of measurements of thyroid function enables quick screening for AHDS in males presenting with cognitive impairment, congenital hypotonia, and generalized muscle weakness.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17574010      PMCID: PMC2094733          DOI: 10.1016/j.beem.2007.03.009

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  25 in total

1.  Unexpected peripheral markers of thyroid function in a patient with a novel mutation of the MCT8 thyroid hormone transporter gene.

Authors:  V Herzovich; E Vaiani; R Marino; G Dratler; J M Lazzati; S Tilitzky; P Ramirez; S Iorcansky; M A Rivarola; A Belgorosky
Journal:  Horm Res       Date:  2006-09-15

2.  X-linked MCT8 gene mutations: characterization of the pediatric neurologic phenotype.

Authors:  Kenton R Holden; Oscar F Zuñiga; Melanie M May; Humberto Su; Marco R Molinero; R Curtis Rogers; Charles E Schwartz
Journal:  J Child Neurol       Date:  2005-10       Impact factor: 1.987

Review 3.  Hypothalamic thyroid hormone feedback in health and disease.

Authors:  Eric Fliers; Anneke Alkemade; Wilmar M Wiersinga; Dick F Swaab
Journal:  Prog Brain Res       Date:  2006       Impact factor: 2.453

Review 4.  Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases.

Authors:  Antonio C Bianco; Domenico Salvatore; Balázs Gereben; Marla J Berry; P Reed Larsen
Journal:  Endocr Rev       Date:  2002-02       Impact factor: 19.871

Review 5.  Clinical utility of sex hormone-binding globulin measurement.

Authors:  M Pugeat; J C Crave; J Tourniaire; M G Forest
Journal:  Horm Res       Date:  1996

Review 6.  Plasma membrane transport of thyroid hormones and its role in thyroid hormone metabolism and bioavailability.

Authors:  G Hennemann; R Docter; E C Friesema; M de Jong; E P Krenning; T J Visser
Journal:  Endocr Rev       Date:  2001-08       Impact factor: 19.871

Review 7.  Role of thyroid hormone during early brain development.

Authors:  Gabriella Morreale de Escobar; María Jesús Obregon; Francisco Escobar del Rey
Journal:  Eur J Endocrinol       Date:  2004-11       Impact factor: 6.664

8.  Enhanced activity of the purine nucleotide cycle of the exercising muscle in patients with hyperthyroidism.

Authors:  H Fukui; S Taniguchi ; Y Ueta; A Yoshida; A Ohtahara; I Hisatome; C Shigemasa
Journal:  J Clin Endocrinol Metab       Date:  2001-05       Impact factor: 5.958

9.  Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation.

Authors:  Edith C H Friesema; Annette Grueters; Heike Biebermann; Heiko Krude; Arpad von Moers; Maarten Reeser; Timothy G Barrett; Edna E Mancilla; Johan Svensson; Monique H A Kester; George G J M Kuiper; Sahila Balkassmi; André G Uitterlinden; Josef Koehrle; Patrice Rodien; Andrew P Halestrap; Theo J Visser
Journal:  Lancet       Date:  2004 Oct 16-22       Impact factor: 79.321

10.  A novel transmembrane transporter encoded by the XPCT gene in Xq13.2.

Authors:  R G Lafrenière; L Carrel; H F Willard
Journal:  Hum Mol Genet       Date:  1994-07       Impact factor: 6.150

View more
  42 in total

1.  Mct8-deficient mice have increased energy expenditure and reduced fat mass that is abrogated by normalization of serum T3 levels.

Authors:  Caterina Di Cosmo; Xiao-Hui Liao; Honggang Ye; Alfonso Massimiliano Ferrara; Roy E Weiss; Samuel Refetoff; Alexandra M Dumitrescu
Journal:  Endocrinology       Date:  2013-09-12       Impact factor: 4.736

Review 2.  Maternal Hypothyroxinemia-Induced Neurodevelopmental Impairments in the Progeny.

Authors:  Hui Min; Jing Dong; Yi Wang; Yuan Wang; Weiping Teng; Qi Xi; Jie Chen
Journal:  Mol Neurobiol       Date:  2015-02-11       Impact factor: 5.590

3.  Distinct roles of deiodinases on the phenotype of Mct8 defect: a comparison of eight different mouse genotypes.

Authors:  Xiao-Hui Liao; Caterina Di Cosmo; Alexandra M Dumitrescu; Arturo Hernandez; Jacqueline Van Sande; Donald L St Germain; Roy E Weiss; Valerie Anne Galton; Samuel Refetoff
Journal:  Endocrinology       Date:  2011-02-01       Impact factor: 4.736

Review 4.  Novel thyroid hormones.

Authors:  Riccardo Zucchi; Grazia Rutigliano; Federica Saponaro
Journal:  Endocrine       Date:  2019-07-20       Impact factor: 3.633

5.  Sobetirome and its Amide Prodrug Sob-AM2 Exert Thyromimetic Actions in Mct8-Deficient Brain.

Authors:  Soledad Bárez-López; Meredith D Hartley; Carmen Grijota-Martínez; Thomas S Scanlan; Ana Guadaño-Ferraz
Journal:  Thyroid       Date:  2018-06-29       Impact factor: 6.568

6.  Tissue distribution and thyroid hormone effects on mRNA abundance for membrane transporters Mct8, Mct10, and organic anion-transporting polypeptides (Oatps) in a teleost fish.

Authors:  Amanda M Muzzio; Pamela D Noyes; Heather M Stapleton; Sean C Lema
Journal:  Comp Biochem Physiol A Mol Integr Physiol       Date:  2013-10-08       Impact factor: 2.320

7.  Targeting Fatty-Acid Amide Hydrolase with Prodrugs for CNS-Selective Therapy.

Authors:  J Matthew Meinig; Skylar J Ferrara; Tania Banerji; Tapasree Banerji; Hannah S Sanford-Crane; Dennis Bourdette; Thomas S Scanlan
Journal:  ACS Chem Neurosci       Date:  2017-08-18       Impact factor: 4.418

8.  RLIM Is a Candidate Dosage-Sensitive Gene for Individuals with Varying Duplications of Xq13, Intellectual Disability, and Distinct Facial Features.

Authors:  Elizabeth E Palmer; Renee Carroll; Marie Shaw; Raman Kumar; Andre E Minoche; Melanie Leffler; Lucinda Murray; Rebecca Macintosh; Dale Wright; Chris Troedson; Fiona McKenzie; Sharron Townshend; Michelle Ward; Urwah Nawaz; Anja Ravine; Cassandra K Runke; Erik C Thorland; Marybeth Hummel; Nicola Foulds; Olivier Pichon; Bertrand Isidor; Cédric Le Caignec; Bénédicte Demeer; Joris Andrieux; Salam Hadah Albarazi; Ann Bye; Rani Sachdev; Edwin P Kirk; Mark J Cowley; Mike Field; Jozef Gecz
Journal:  Am J Hum Genet       Date:  2020-11-06       Impact factor: 11.025

9.  Prenatal thyroxine treatment disparately affects peripheral and amygdala thyroid hormone levels.

Authors:  Pradeep K Shukla; Laura J Sittig; Brian M Andrus; Daniel J Schaffer; Kanchi K Batra; Eva E Redei
Journal:  Psychoneuroendocrinology       Date:  2009-12-11       Impact factor: 4.905

10.  A thyroid hormone analog with reduced dependence on the monocarboxylate transporter 8 for tissue transport.

Authors:  Caterina Di Cosmo; Xiao-Hui Liao; Alexandra M Dumitrescu; Roy E Weiss; Samuel Refetoff
Journal:  Endocrinology       Date:  2009-06-04       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.